Wendy Langeberg

Wendy Langeberg currently serves as Clinical Development Associate Director at A2 Biotherapeutics, Inc., since June 2023. Prior to this role, Wendy worked as a Freelance Regulatory Writer at Waterford Writing, LLC, from June 2019 to June 2023, and as Regulatory Writing Senior Manager at Kite Pharma from July 2018 to June 2019. Wendy's extensive experience includes positions at Amgen, where roles included Regulatory Writing Manager, Epidemiology Senior Manager, and Epidemiology Manager, from April 2009 to July 2018. Earlier in Wendy's career, roles included Graduate Research Assistant at Fred Hutchinson Cancer Research Center, Medical Writer at Spectrum Research, Inc., Research Analyst at Utah Cancer Registry, and Data Analyst at Rocky Mountain Health Plans. Wendy holds a PhD in Epidemiology from the University of Washington and a BS and MPH in Public Health from the University of Utah.